The two highest volume trading days for Recce are 9 July and 16 July this year with about 4.1 million and 3.7 millions shares respectively. It comes as no surprise that these were days after COVID related announcements were released. The first was the announcement of partnering with CSIRO for trials and the second was announcement of testing with a US research facility.
For me this shows that there is significant market visibility and people are watching the shares - just waiting for some good news to get in. The first announcement led to an approx 50% jump from $0.68 to $1.05. The second was about 26% from $1.145 to $1.45.
Any positive news on COVID will see a significant rise IMO. And don't forget Phase 1 human trials fro Recce 327 around the corner, and Phase 1/2 trials for the topical application!
GLTAH
RCE Price at posting:
$1.35 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)